Alvotech Eyes Canada Humira Launch As Celltrion Also Bags High-Strength Approval
Celltrion’s Yuflyma And Alvotech/JAMP’s Simlandi Approved By Health Canada
Executive Summary
The first biosimilar approval stemming from Alvotech’s collaboration with JAMP Pharma in Canada has arrived, with the firms’ Simlandi (adalimumab) biosimilar version of AbbVie’s higher-strength Humira. Celltrion has also announced an approval from Health Canada.